| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/138920211795677877 |
| P8608 | Fatcat ID | release_ky2nskkmkraarjqvm3ht3lsq5i |
| P932 | PMC publication ID | 3137005 |
| P698 | PubMed publication ID | 22043168 |
| P5875 | ResearchGate publication ID | 51760474 |
| P2093 | author name string | Merlin G Butler | |
| P2860 | cites work | Identification of Four Highly Conserved Genes between Breakpoint Hotspots BP1 and BP2 of the Prader-Willi/Angelman Syndromes Deletion Region That Have Undergone Evolutionary Transposition Mediated by Flanking Duplicons | Q24532789 |
| Genomic imprinting disorders in humans: a mini-review | Q24646016 | ||
| Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster | Q24653893 | ||
| Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome | Q47331870 | ||
| C15orf2 and a novel noncoding transcript from the Prader-Willi/Angelman syndrome region show monoallelic expression in fetal brain | Q48253408 | ||
| The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. | Q48401644 | ||
| Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study | Q48663060 | ||
| Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. | Q50312488 | ||
| Obsessions and compulsions in Prader-Willi syndrome. | Q50959818 | ||
| Prader-Willi syndrome. | Q51886650 | ||
| Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. | Q52001908 | ||
| Psychotic disorders in Prader-Willi syndrome. | Q52089471 | ||
| Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. | Q52170199 | ||
| Emotional symptoms in Prader-Willi syndrome adolescents. | Q52583296 | ||
| Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. | Q55035652 | ||
| A 5-year-old white girl with Prader-Willi syndrome and a submicroscopic deletion of chromosome 15q11q13. | Q55044754 | ||
| Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. | Q55117910 | ||
| Whole genome microarray analysis of gene expression in Prader-Willi syndrome. | Q55159900 | ||
| An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype. | Q55507993 | ||
| Food and children with Prader-Willi syndrome | Q67829369 | ||
| Standards for selected anthropometric measurements in Prader-Willi syndrome | Q67979069 | ||
| Adults with Prader-Willi syndrome: a survey of 232 cases | Q69022332 | ||
| Prader-Willi syndrome | Q70322955 | ||
| Prader-Willi syndrome. A resumé of 32 cases including an instance of affected first cousins, one of whom is of normal stature and intelligence | Q70415480 | ||
| Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably | Q74337455 | ||
| Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity | Q79297696 | ||
| Management of obesity in Prader-Willi syndrome | Q79327042 | ||
| Clinical report—health supervision for children with Prader-Willi syndrome | Q83039727 | ||
| A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism | Q24655126 | ||
| Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD | Q24676625 | ||
| Neural mechanisms underlying hyperphagia in Prader-Willi syndrome | Q24681618 | ||
| Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy | Q28247810 | ||
| Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology | Q28263222 | ||
| The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C | Q28287199 | ||
| Are jigsaw puzzle skills 'spared' in persons with Prader-Willi syndrome? | Q33337095 | ||
| Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome | Q33752509 | ||
| Prader-Willi syndrome: current understanding of cause and diagnosis | Q33858951 | ||
| Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities | Q33864044 | ||
| Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome | Q33864953 | ||
| Parental origin of chromosome 15 deletion in Prader-Willi syndrome | Q33904998 | ||
| The role of genomic imprinting in human developmental disorders: lessons from Prader-Willi syndrome | Q34190554 | ||
| Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome | Q34289870 | ||
| A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome | Q34326210 | ||
| Expression of SNURF-SNRPN upstream transcripts and epigenetic regulatory genes during human spermatogenesis | Q34327357 | ||
| Imprinting-mutation mechanisms in Prader-Willi syndrome | Q34388796 | ||
| Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes | Q34433463 | ||
| Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. | Q34460866 | ||
| Hypogonadism and pubertal development in Prader-Willi syndrome. | Q34532776 | ||
| Gastric rupture and necrosis in Prader-Willi syndrome | Q34581542 | ||
| Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. | Q34680586 | ||
| Deletions of chromosome 15 as a cause of the Prader-Willi syndrome | Q34718526 | ||
| Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome. | Q35197277 | ||
| Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients | Q35643492 | ||
| Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. | Q37089973 | ||
| Prader-Willi Syndrome: Clinical and Genetic Findings | Q37201174 | ||
| Recommendations for the diagnosis and management of Prader-Willi syndrome | Q37242208 | ||
| Is gestation in Prader-Willi syndrome affected by the genetic subtype? | Q37399911 | ||
| Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations | Q37600857 | ||
| Clinical and genetic aspects of Angelman syndrome | Q37743131 | ||
| Visual capacity and Prader-Willi syndrome | Q39346054 | ||
| Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes | Q41544376 | ||
| Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect | Q42156745 | ||
| The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome | Q46041934 | ||
| Prader-Willi syndrome: are there population differences? | Q46338323 | ||
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| Prader–Willi syndrome | Q594013 | ||
| P304 | page(s) | 204-215 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Current Genomics | Q5195047 |
| P1476 | title | Prader-Willi Syndrome: Obesity due to Genomic Imprinting | |
| P478 | volume | 12 |
| Q48304775 | A Resource for the Allele-Specific Analysis of DNA Methylation at Multiple Genomically Imprinted Loci in Mice. |
| Q36157140 | A clinical follow-up of 35 Brazilian patients with Prader-Willi syndrome |
| Q36255013 | A compendium of human genes regulating feeding behavior and body weight, its functional characterization and identification of GWAS genes involved in brain-specific PPI network |
| Q27333802 | A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men |
| Q92778186 | A study of voice and non-voice processing in Prader-Willi syndrome |
| Q37001192 | A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report |
| Q26853110 | Adenosine-to-inosine RNA editing and human disease |
| Q33627621 | Adult-onset deletion of the Prader-Willi syndrome susceptibility gene Snord116 in mice results in reduced feeding and increased fat mass |
| Q64120568 | Analysis of the Prader-Willi syndrome imprinting center using droplet digital PCR and next-generation whole-exome sequencing |
| Q89397661 | Autoimmune pituitary involvement in Prader-Willi syndrome: new perspective for further research |
| Q38830153 | Benefits and limitations of prenatal screening for Prader-Willi syndrome |
| Q33699914 | Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey |
| Q39381468 | Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2. |
| Q48285694 | Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA. |
| Q54145593 | Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. |
| Q34461103 | Clinical Presentation and Microarray Analysis of Peruvian Children with Atypical Development and/or Aberrant Behavior |
| Q38703279 | Clinical and Molecular Characterization of Prader-Willi Syndrome. |
| Q35236656 | Clinically relevant known and candidate genes for obesity and their overlap with human infertility and reproduction |
| Q35100466 | Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alström syndromes. |
| Q37689619 | Congenital Arthrogryposis: An Extension of the 15q11.2 BP1-BP2 Microdeletion Syndrome? |
| Q48314797 | Craniofacial morphology in pediatric patients with Prader-Willi syndrome: a retrospective study. |
| Q84824102 | Development and implementation of electronic growth charts for infants with Prader-Willi syndrome |
| Q35794745 | Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children |
| Q34228077 | Differential regulation of non-protein coding RNAs from Prader-Willi Syndrome locus. |
| Q33851054 | Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome |
| Q34086815 | Effects of growth hormone treatment in adults with Prader-Willi syndrome |
| Q52665859 | Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings. |
| Q64915302 | Environmental and Nutritional Effects Regulating Adipose Tissue Function and Metabolism Across Generations. |
| Q89938616 | Examination of Global Methylation and Targeted Imprinted Genes in Prader-Willi Syndrome |
| Q89805560 | Food and Non-Food-Related Behavior across Settings in Children with Prader-Willi Syndrome |
| Q34183041 | Frequency of Prader-Willi syndrome in births conceived via assisted reproductive technology |
| Q92989043 | GENETIC AND EPIGENETIC CAUSES OF OBESITY |
| Q40026342 | Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment. |
| Q34785419 | Growth charts for non-growth hormone treated Prader-Willi syndrome |
| Q86838676 | Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome |
| Q33726962 | Growth hormone treatment in non-growth hormone-deficient children |
| Q37213617 | GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome |
| Q90701482 | Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health |
| Q55059019 | High plasma neurotensin levels in children with Prader-Willi syndrome. |
| Q35381777 | High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders |
| Q53084115 | Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls. |
| Q88115461 | Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls |
| Q52688996 | Human exposure to flame-retardants is associated with aberrant DNA methylation at imprinted genes in sperm. |
| Q34227904 | Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differentiation |
| Q86759655 | Increased plasma chemokine levels in children with Prader-Willi syndrome |
| Q34407440 | Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes |
| Q38957320 | Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study |
| Q40151997 | Long-term health outcomes in patients with Prader-Willi syndrome: a nationwide cohort study in Denmark |
| Q58608069 | Makorin 1 Regulates Developmental Timing in Drosophila |
| Q36548772 | Maternal transcription of non-protein coding RNAs from the PWS-critical region rescues growth retardation in mice. |
| Q36029803 | Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone |
| Q35836803 | Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome |
| Q39003471 | Model mice for 15q11-13 duplication syndrome exhibit late-onset obesity and altered lipid metabolism. |
| Q36851398 | Molecular characterization of a patient presumed to have prader-willi syndrome. |
| Q38079927 | Mouse models of Prader-Willi Syndrome: a systematic review |
| Q37690666 | Natural breaking of the maternal silence at the mouse and human imprinted Prader-Willi locus: A whisper with functional consequences. |
| Q37624723 | Obesity in adults with 22q11.2 deletion syndrome. |
| Q89635517 | Oral disorders in children with Prader-Willi syndrome: a case control study |
| Q91906549 | Oral health in patients with Prader-Willi syndrome: current perspectives |
| Q34554940 | Polymorphisms in the SNRPN gene are associated with obesity susceptibility in a Spanish population |
| Q92102618 | Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update |
| Q44293368 | Prader-Willi Syndrome due to an Unbalanced de novo Translocation t(15;19)(q12;p13.3). |
| Q38691540 | Prader-Willi Syndrome: A spectrum of anatomical and clinical features |
| Q38642369 | Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches. |
| Q47996068 | Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects. |
| Q53480964 | Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study. |
| Q34077985 | Prader-Willi syndrome and growth hormone deficiency |
| Q36240989 | Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings |
| Q50850661 | Prediction of basal metabolic rate in patients with Prader-Willi syndrome. |
| Q56977965 | Preliminary observations of mitochondrial dysfunction in Prader-Willi syndrome |
| Q41628976 | SNORD116 and SNORD115 change expression of multiple genes and modify each other's activity |
| Q38862130 | Single Gene and Syndromic Causes of Obesity: Illustrative Examples |
| Q47718746 | Stem Cell Technology for (Epi)genetic Brain Disorders. |
| Q31138426 | Stochastic loss of silencing of the imprinted Ndn/NDN allele, in a mouse model and humans with prader-willi syndrome, has functional consequences |
| Q54505713 | Subclinical dysphagia in persons with Prader-Willi syndrome. |
| Q47167593 | Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey |
| Q64120183 | TET3 prevents terminal differentiation of adult NSCs by a non-catalytic action at Snrpn |
| Q28078294 | The neurobiology of the Prader-Willi phenotype of fragile X syndrome |
| Q47594473 | Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome |
| Q30465782 | Transcript diversification in the nervous system: a to I RNA editing in CNS function and disease development |
| Q38503454 | Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans. |
| Q35976911 | Weight control and behavior rehabilitation in a patient suffering from Prader Willi syndrome |
| Q52870195 | [Monogenic and syndromic symptoms of morbid obesity. Rare but important]. |
| Q92106567 | miRNA-Gene Regulatory Network in Gnotobiotic Mice Stimulated by Dysbiotic Gut Microbiota Transplanted From a Genetically Obese Child |
Search more.